Antiinflammatory lanostane triterpenoids from Ganoderma lucidum

References

• Amen YM, Zhu Q, Tran HB, Afifi MS, Halim AF, Ashour A, Mira A, Shimizu K. 2016. Lucidumol C, a new cytotoxic lanostanoid triterpene from Ganoderma lingzhi against human cancer cells. J Nat Med. 70(3):661–666.
   PubMed Web of Science ®Google Scholar
• Carrieri R, Manco R, Sapio D, Iannaccone M, Fulgione A, Papaianni M, de Falco B, Grauso L, Tarantino P, Ianniello F, et al. 2017. Structural data and immunomodulatory properties of a water-soluble heteroglycan extracted from the mycelium of an Italian isolate of Ganoderma lucidum. Nat Prod Res. 31(18):2119–2125.
   PubMed Web of Science ®Google Scholar
• Chen XQ, Chen LX, Zhao J, Tang YP, Li SP. 2017. Nortriterpenoids from the fruiting bodies of the mushroom Ganoderma resinaceum. Molecules. 22(7):1073.
   Web of Science ®Google Scholar
• Chen X, Hu ZP, Yang XX, Huang M, Gao Y, Tang W, Chan SY, Dai X, Ye J, Ho PC, et al. 2006. Monitoring of immune response to a herbal immune-modulator in patients with advanced colorectal cancer. Int J Immunopharmacol. 6(3):499–508.
   Web of Science ®Google Scholar
• Eo SK, Kim YS, Lee CK, Han SS. 1999. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacol. 68(1-3):129–136.
   PubMed Web of Science ®Google Scholar
• Fatmawati S, Shimizu K, Kondo R. 2010. Ganoderic acid Df, a new triterpenoid with aldose reductase activity from the fruiting body of Ganoderma lucidum. Fitoterapia. 81(8):1033–1036.
   PubMed Web of Science ®Google Scholar
• Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y, et al. 2005. Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol. 102(1):107–112.
   PubMed Web of Science ®Google Scholar
• Hajjaj H, Mace C, Roberts M, Niederberger P, Fay LB. 2005. Effect of 26-oxygenosterols from Ganoderma lucidum and their activity as cholesterol synthesis inhibitors. Appl Environ Microbiol. 71(7):3653–3658.
   PubMed Web of Science ®Google Scholar
• Hikino H, Ishiyama M, Suzuki Y, Konno C. 1989. Mechanisms of hypoglycaemic activity of ganoderan B: a glycan of Ganoderma lucidum fruit bodies. Planta Med. 55(05):423–428.
   PubMedGoogle Scholar
• Hirotani M, Furuya T, Shiro M. 1985. Studies on the metabolites of higher fungi. Part 4. A ganoderic acid derivative, a highly oxygenated lanostane-type triterpenoid from Ganoderma lucidum. Phytochemistry. 24(9):2055–2061.
   Web of Science ®Google Scholar
• Hirotani M, Ino C, Furuya T. 1993. Comparative study on the strain-specific triterpenoid components of Ganoderma lucidum. Phytochemistry. 33(2):379–382.
   Web of Science ®Google Scholar
• Joseph S, Sabulal B, George V, Smina TP, Janardhanan KK. 2009. Antioxidative and antiinflammatory activities of the chloroform extract of Ganoderma lucidum found in south India. Sci Pharm. 77(1):111–121.
   Google Scholar
• Kikuchi T, Kanomi S, Murai Y, Kadota S, Tsubono K, Ogita Z. 1986. Constituents of the fungus Ganoderma lucidum (fr.) Karst. II. Structures of ganoderic acids F, G, and H, lucidenic acids D2 and E2, and related compounds. Chem Pharm Bull. 34(10):4018–4029.
   Web of Science ®Google Scholar
• Kikuchi T, Kanomi S, Murai Y, Kadota S, Tsubono K, Ogita Z. 1986. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. III. Structures of ganolucidic acids A and B, new lanostane-type triterpenoids. Chem Pharm Bull. 34(10):4030–4036.
   Web of Science ®Google Scholar
• Ko HH, Hung CF, Wang JP, Lin CN. 2008. Antiinflammatory triterpenoids and steroids from Ganoderma lucidum and G. tsugae. Phytochemistry. 69(1):234–239.
   PubMed Web of Science ®Google Scholar
• Komoda Y, Nakamura H, Ishihara S, Uchida M, Kohda H, Yamasaki K. 1985. Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) Karst (Polyporaceae). Chem Pharm Bull. 33(11):4829–4835.
   Web of Science ®Google Scholar
• Kuo PC, Schroeder RA. 1995. The emerging multifaceted roles of nitric oxide. Ann Surg. 221(3):220–235.
   PubMed Web of Science ®Google Scholar
• Lee JM, Kwon H, Jeong H, Lee JW, Lee SY, Baek SJ, Surh YJ. 2001. Inhibition of lipid peroxidation and oxidative DNA damage by Ganoderma lucidum. Phytother Res. 15(3):245–249.
   PubMed Web of Science ®Google Scholar
• Li C, Li Y, Sun HH. 2006. New ganoderic acids, bioactive triterpenoid metabolites from the mushroom Ganoderma lucidum. Nat Prod Res. 20(11):985–991.
   PubMed Web of Science ®Google Scholar
• Li NS, Yan CY, Hua DH, Zhang DZ. 2013. Isolation, purification, and structural characterization of a novel polysaccharide from Ganoderma capense. Int J Biol Macromol. 57:285–290.
   PubMed Web of Science ®Google Scholar
• Li C, Yin J, Guo F, Zhang D, Sun HH. 2005. Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat Prod Res. 19(5):461–465.
   PubMed Web of Science ®Google Scholar
• Min BS, Nakamura N, Miyashiro H, Bae KW, Hattori M. 1998. Triterpenes from the spores of Ganoderma lucidum and their inhibitory effect against HIV-1 protease. Chem Pharm Bull. 46(10):1607–1612.
   PubMed Web of Science ®Google Scholar
• Mizushina Y, Hanashima L, Yamaguchi T, Takemura M, Sugawara F, Saneyoshi M, Matsukage A, Yoshida S, Sakaguchi K. 1998. A mushroom fruiting bodyinducing substance inhibits activities of replicative DNA polymerases. Biochem Biophys Res Commun. 249(1):17–22.
   PubMed Web of Science ®Google Scholar
• Muller CI, Kumagai T, O'Kelly J, Seeram NP, Heber D, Koeffler HP. 2006. Ganoderma lucidum causes apoptosis in leukemia, lymphoma and multiple myeloma cells. Leuk Res. 30:841–848.
   PubMed Web of Science ®Google Scholar
• Nishitoba T, Sato H, Oda K, Sakamura S. 1988. Novel triterpenoids and a steroid from the fungus Ganoderma lucidum. Agric Biol Chem. 52:211–216.
   Web of Science ®Google Scholar
• Nishitoba T, Sato H, Sakamura S. 1985. New terpenoids from Ganoderma lucidum and their bitterness. Agric Biol Chem. 49:1547–1549.
   Web of Science ®Google Scholar
• Park EJ, Kondratyuk TP, Morrell A, Kiselev E, Conda-Sheridan M, Cushman M, Ahn S, Choi Y, White JJ, van Breemen RB, et al. 2011. Induction of retinoid X receptor activity and consequent upregulation of p21WAF1​/CIP1 by indenoisoquinolines in MCF7 cells. Cancer Prev Res (Phila). 4(4):592–607.
   PubMed Web of Science ®Google Scholar
• Peng XR, Liu JQ, Han ZH, Yuan XX, Luo HR, Qiu MH. 2013. Protective effects of triterpenoids from Ganoderma resinaceum on H2O2-induced toxicity in HepG2 cells. Food Chem. 141(2):920–926.
   PubMed Web of Science ®Google Scholar
• Rios JL, Andujar I, Recio MC, Giner RM. 2012. Lanostanoids from fungi: a group of potential anticancer compounds. J Nat Prod. 75:2016–2044.
   PubMed Web of Science ®Google Scholar
• Ruan W, Lim AHH, Huang LG, Popovich DG. 2014. Extraction optimisation and isolation of triterpenoids from Ganoderma lucidum and their effect on human carcinoma cell growth. Nat Prod Res. 28(24):2264–2272.
   PubMed Web of Science ®Google Scholar
• Sato H, Nishitoba T, Shirasu S, Oda K, Sakamura S. 1986. Ganoderiol A and B, new triterpenoids from the fungus Ganoderma lucidum (Reishi). Agric Biol Chem. 50:2887–2890.
   Web of Science ®Google Scholar
• Seo HW, Hung TM, Na MK, Jung HJ, Kim JC, Choi JS, Kim JH, Lee HK, Lee IS, Bae KH, et al. 2009. Steroids and triterpenes from the fruit bodies of Ganoderma lucidum and their anti-complement activity. Arch Pharm Res. 32(11):1573–1579.
   PubMed Web of Science ®Google Scholar
• Shie YH, Liu CF, Huang YK, Yang JY, Wu IL, Lin CH, Li SC. 2001. Evaluation of the hepatic and renal protective effects of Ganoderma lucidum in mice. Am J Chin Med. 29:501–507.
   PubMed Web of Science ®Google Scholar
• Vincent JL, Zhang H, Szabo C, Preiser JC. 2000. Effects of nitric oxide in septic shock. Am J Respir Crit Care Med. 161(6):1781–1785.
   PubMed Web of Science ®Google Scholar
• Wang CF, Liu JQ, Yan YX, Chen JC, Lu Y, Guo YH, Qiu MH. 2010. Three new triterpenoids containing four-membered ring from the fruiting body of Ganoderma sinense. Org Lett. 12(8):1656–1659.
   PubMed Web of Science ®Google Scholar
• Wasser SP, Weis AL. 1999. Therapeutic effects of substance occurring in higher basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 19:65–96.
   PubMed Web of Science ®Google Scholar
• Yoon SY, Eo SK, Kim YS, Lee CK, Han SS. 1994. Antimicrobial activity of Ganoderma lucidum extract alone and in combination with some antibiotics. Arch Pharm Res. 17(6):438–442.
   PubMedGoogle Scholar
• Zhang CR, Yang SP, Yue JM. 2008. Sterols and triterpenoids from the spores of Ganoderma lucidum. Nat Prod Res. 22(13):1137–1142.
   PubMed Web of Science ®Google Scholar